Metformin

Dr. McPhee: Excellent choice! Metformin is the most appropriate drug for Mr. Green, who has no signs of kidney or hepatic dysfunction and no compelling co-morbidity to indicate that one of the newer, more expensive medications, is indicated. Metformin can be useful in overweight patients. Additionally, it has cardiovascular benefits, which are important given Mr. Green’s history of hypertension.  

In addition to prescribing metformin, Dr McPhee explains that they need to monitor his blood pressure to ensure continued control and gives Mr. Green lifestyle advice, as it forms an important part of management of his type 2 diabetes. Mr. Green admits that he has received similar advice in the past but he finds it difficult to comply with these recommendations. Dr. McPhee explains that metformin may also help in reducing weight.

Which pharmacological effect is most likely to occur with metformin in diabetic patients like Mr. Green?




  • Decreased production of glucose from the liver
  • Increased entry of fatty acids into adipocytes
  • Increased secretion of insulin from the pancreas
  • Decreased entry of glucose into muscle cells
End Session and View Feedback
  • Verify patient identity and obtain e-consent before starting. [undo]
  • Allow the family member to stay on screen without clarifying their role [undo]
  • Use open-ended questions and clarify priority symptoms (pain, discharge, fever). [undo]
  • Ask rapid questions using medical jargon (ischemia, necrotic tissue, perfusion). [undo]
  • Ignore the wound complaint and focus solely on blood glucose. [undo]
  • Give an immediate diagnosis without exploring the patient’s narrative. [undo]
  • Connecting Care Virtually: Building Trust and Teamwork in Digital Health Communication [undo]
  • Privacy risk [undo]
  • new node [undo]
  • GP's routine visit [undo]
  • Βλέπεις τον ιατρικό της φάκελο [undo]
  • BrainHQ Συναισθηματικός παράγοντας [undo]
  • Root Node [undo]
  • STUCTURA ȘI FUNCȚIILE CELULEI [undo]
  • ΗΛΕΚΤΡΟΝΙΚΗ ΜΙΚΡΟΣΚΟΠΙΑ [undo]
  • go to espresso house [undo]
  • Furosemide (loop diuretic) [undo]
  • Examination [undo]
  • START [undo]
  • Bisoprolol (Beta-blocker) [undo]
  • Glycerol trinitrate (organic nitrate) [undo]
  • Dobutamine (beta agonist) [undo]
  • Empagliflozin [undo]
  • Metformin [undo]

Map: Michael Green_GEMD_2 (1116)
Node: 21111
Score:

reset

OpenLabyrinth
OpenLabyrinth is an open source educational pathway system

Review your pathway

  • Start the consultation without verification
  • Verify patient identity and obtain e-consent before starting.
  • Allow the family member to stay on screen without clarifying their role
  • Use open-ended questions and clarify priority symptoms (pain, discharge, fever).
  • Ask rapid questions using medical jargon (ischemia, necrotic tissue, perfusion).
  • Ignore the wound complaint and focus solely on blood glucose.
  • Give an immediate diagnosis without exploring the patient’s narrative.
  • Connecting Care Virtually: Building Trust and Teamwork in Digital Health Communication
  • Privacy risk
  • new node
  • GP's routine visit
  • Βλέπεις τον ιατρικό της φάκελο
  • BrainHQ Συναισθηματικός παράγοντας
  • Root Node
  • STUCTURA ȘI FUNCȚIILE CELULEI
  • ΗΛΕΚΤΡΟΝΙΚΗ ΜΙΚΡΟΣΚΟΠΙΑ
  • go to espresso house
  • Furosemide (loop diuretic)
  • new node
  • Examination
  • START
  • Bisoprolol (Beta-blocker)
  • Glycerol trinitrate (organic nitrate)
  • Dobutamine (beta agonist)
  • Empagliflozin
  • Metformin

Reminder

empty_reminder_msg

FINISH

Time is up